Literature DB >> 31269372

A First Step toward a New Approach to Treating Membranous Nephropathy.

Piero Ruggenenti1, Giuseppe Remuzzi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31269372     DOI： 10.1056/NEJMe1906666

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

1.  Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness.

Authors:  Manuel Alfredo Podestà; Barbara Ruggiero; Giuseppe Remuzzi; Piero Ruggenenti
Journal:  BMJ Case Rep       Date:  2020-01-23

Review 2.  Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood.

Authors:  Antonio Mastrangelo; Jessica Serafinelli; Marisa Giani; Giovanni Montini
Journal:  Front Pediatr       Date:  2020-05-12       Impact factor: 3.418

3.  Salvianolic acid B attenuates membranous nephropathy by activating renal autophagy via microRNA-145-5p/phosphatidylinositol 3-kinase/AKT pathway.

Authors:  Junqi Chen; Qinghong Hu; Yini Luo; Lina Luo; Hua Lin; Dandan Chen; Yuan Xu; Bihao Liu; Yu He; Chunling Liang; Yaoyu Liu; Jiuyao Zhou; Junbiao Wu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Rituximab Therapy for Primary Membranous Nephropathy in a Chinese Cohort.

Authors:  Shuang Gao; Zhao Cui; Xin Wang; Yi-Miao Zhang; Fang Wang; Xu-Yang Cheng; Li-Qiang Meng; Fu-de Zhou; Gang Liu; Ming-Hui Zhao
Journal:  Front Med (Lausanne)       Date:  2021-05-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.